Clinical Trials Directory

Trials / Completed

CompletedNCT04795674

Target ADHD Executive Working Memory Study

Behavioral and Neural Target Engagement for ADHD Executive Working Memory Training

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
62 (actual)
Sponsor
Hartford Hospital · Academic / Other
Sex
All
Age
12 Years – 18 Years
Healthy volunteers
Not accepted

Summary

This study will assess whether or not a novel executive working memory training intervention for Attention-Deficit/Hyperactivity Disorder can engage frontoparietal brain network treatment targets and behavioral performance.

Detailed description

This proposal seeks support for a 2-year milestone-driven R61 initial test of target engagement in n=62 ADHD diagnosed adolescents randomized to a 'sham training' placebo or to train 4 times each week using 4 different EWM exercises that have been combined into the format of a typical cognitive training intervention. Exercise difficulty levels in the active intervention will increase across 5 weeks to continually challenge EWM ability. EWM training will use a novel, remotely-supervised 'at home' computerized training approach. If R61 EWM training target engagement milestones are met, a 3-year R33 phase will begin. The R33 will replicate target engagement in another randomized placebo-controlled trial of n=90 new ADHD adolescents and attempt to establish a convincing link between the hypothesized targets and ADHD symptom expression. It also will characterize ADHD brain activity or EWM ability changes relative to typical levels seen in an n=40 non-ADHD control group.

Conditions

Interventions

TypeNameDescription
BEHAVIORALEWM TrainingTraining tasks will target Executive Working Memory areas of the brain. Task difficulty will be adaptively increased across the 5 weeks of training based on session-to-session performance.
BEHAVIORALPlacebo TrainingComputerized tasks with comparable engagement that do not tap executive working memory processes

Timeline

Start date
2021-11-01
Primary completion
2023-03-19
Completion
2023-03-19
First posted
2021-03-12
Last updated
2023-08-02

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT04795674. Inclusion in this directory is not an endorsement.